You are here

When Drugs Cause Disease

March 8, 2010 -- The same drugs that are used effectively to treat diseases in millions of people around the world can sometimes be the cause of disease themselves. The American Society of Health-System Pharmacists (ASHP) has just released the 2nd edition of Drug-Induced Diseases: Prevention, Detection and Management, edited by James E. Tisdale, Pharm.D., BCPS, FCCP and Douglas A. Miller, Pharm.D.

According to the authors, a drug-induced disease is an unintended effect of a drug, which results in illness with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. Since the first edition of this book was published in 2005, numerous drugs have been withdrawn from the market in the United States as a result of illness or death associated with drug-induced diseases. Despite best efforts to assure that all drugs are safe and effective, millions of patients each year develop drug-induced diseases. Tisdale and Miller stress that every time a patient presents with a new disease or an exacerbation of an existing condition, someone needs to ask, “Could this be drug-related?”

This popular and essential comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. With contributions from experts distinguished in their respective specialties, Drug-Induced Diseases is organized logically and is easy to use for pharmacists, physicians, nurses, and pharmacy students alike.

To place orders for the book, ISBN 978-1-58528-205-0, and view additional material, please visit www.ashp.org/bookstore. Or, please email custserv@ashp.org or call 1-866-279-0681 (US & Canada), 001-301-664-8700 (International).

Source: American Society of Health-System Pharmacists

Recent Headlines

Possible First Treatment Option for Rare Autoimmune Disease of the CNS
New Hematologic Biomarker Test Provides New Approach to Sepsis Triage and Diagnosis
Antibiotics, Statins, and Glucocorticoids All Show Promise
More Than 32% of Patients Responded in Trial
Current, Sole Therapy Not Always Successful/Suitable
Over 1.5 Million Americans Likely to have Wet AMD by 2020 
Potential For Use Against E. Coli, TB, Resistant Bacteria